ISPE

OCTOBER 26, 2022

Transportable, Small Footprint Biopharmaceutical Manufacturing Facilities: A Regulatory Perspective. iSpeak Blog. Transportable, Small Footprint Biopharmaceutical Manufacturing Facilities: A Regulatory Perspective. Trudy Patterson. Wed, 10/26/2022 - 11:58. O'Brien, PhD. 26 October 2022.

FDA 52

FDA 52

ISPE

AUGUST 30, 2023

Additionally, these principles, systems, and tools ensure business continuity through a stable supply environment, health and safety, and customer satisfaction from existing or new facilities, processes, and manufacturing operations. WuXi Biologics has almost 600 global partners, including all the top 20 pharmaceutical companies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

ISPE

SEPTEMBER 11, 2023

Cauchon, PhD 1 September 2023 The biopharmaceutical industry must develop and implement innovative ways of working to be effective and efficient in the current healthcare ecosystem, in which high-quality medicines, adaptability, and assurance of supply are of critical importance.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52